Hepatitis B vaccination in heart transplant candidates

Journal of Heart and Lung Transplantation

Volumn 25, Issue 1, 2006, Pages 106-109

  Foster, W Quinton ^a   Murphy, Angela ^a   Vega, David J ^a   Smith, Andrew L ^a   Hott, Brenda J ^a   Book, Wendy M ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Emory Adult Congenital Cardiac Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ENGERIX; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

CREATININE BLOOD LEVEL; FUNCTIONAL STATUS; HEART EJECTION FRACTION; HEART FAILURE; HEART TRANSPLANTATION; HEPATITIS B; HUMAN; ORGAN DONOR; PRIORITY JOURNAL; REVIEW; SEROCONVERSION; SEROLOGY; VACCINATION;

EID: 30044434547     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.07.015     Document Type: Article

References (33)

1. L.A. Moyer, E.E. Mast Hepatitis B virology, epidemiology, disease, and prevention, and an overview of viral hepatitis Am J Prevent Med 10 suppl 1994 45 55
2. A.S. Yu, R.C. Cheung, E.B. Keeffe Hepatitis B vaccines Clin Liver Dis 8 2004 283 300
3. United Network for Organ Sharing. Number of hearts transplanted where donor hepatitis BsAg test was positive, 2001-2004 (based on OPTN data).
4. United Network for Organ Sharing. Number of hearts transplanted where donor hepatitis BsAg test was positive, 2001-2004 (based on OPTN data). UNOS online database.
5. United Network for Organ Sharing. Number of donors where heart was not recovered due to positive hepatitis, 2001-2004 (based on OPTN data).
6. M. Blanes, D. Gomez, J. Cordoba Is there any risk of transmission of hepatitis B from heart donors hepatitis B core antibody positive? Transplant Proc 34 2002 61 62
7. Heart Kaplan-Meier median waiting times for registrations listed: 1997-2002. 2005, Organ Procurement and Transplantation Network.
8. Heart Kaplan-Meier percentage transplanted at specific time points for registrations listed: 1997-2002. 2005, Organ Procurement and Transplantation Network.
9. G.A. Poland, R.M. Jacobson Clinical practice prevention of hepatitis B with the hepatitis B vaccine N Engl J Med 351 2004 2832 2838
10. W. Carey Failure of hepatitis B immunization in liver transplant recipients results of a prospective trial Am J Gastroenterol 85 1990 1590 1592
11. C. Loinaz Hepatitis B vaccination results in 140 liver transplant recipients Hepato-Gastroenterology 44 1997 235 238
12. I.M. Jacobson Immunogenicity of hepatitis B vaccine in renal transplant recipients Transplantation 39 1985 393 395
13. D.H. Van Thiel Response to hepatitis B vaccination by liver transplant candidates Digest Dis Sci 37 1992 1245 1249
14. P.J. Grob Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients Antiviral Res 3 1983 43 52
15. W. Szmuness Hepatitis B vaccine demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States N Engl J Med 303 1980 833 841
16. J.L. Renard Acute transverse cervical myelitis following hepatitis B vaccination. Evolution of anti-HBs antibodies Presse Med 28 1999 1290 1292
17. J.F. Maillefert Rheumatic disorders developed after hepatitis B vaccination Rheumatology 38 1999 978 983
18. D.J. Weber Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine JAMA 254 1985 3187 3189
19. F.B. Hollinger Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations Am J Med 87 suppl 3A 1989 36S 40S
20. A.P. Winter Influence of smoking on immunological responses to hepatitis B vaccine Vaccine 12 1994 771 772
21. J. Germanaud, J.P. Barthez Immunogenicity of hepatitis B vaccines JAMA 272 1994 202
22. S.C. Hadler Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians Vaccine 7 1989 106 110
23. B. Durupinar, G. Okten HLA tissue types in nonresponders to hepatitis B vaccine Ind J Pediatr 63 1996 369 373
24. M.J. Nowicki, M.J. Tong, R.E. Bohman Alterations in the immune response of nonresponders to the hepatitis B vaccine J Infect Dis 152 1985 1245 1248
25. R.C. Wood Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers JAMA 270 1993 2935 2939
26. G.A. Poland Hepatitis B immunization in health care workers. Dealing with vaccine nonresponse Am J Prevent Med 15 1998 73 77
27. S.P. Pinney, F.H. Cheema, K. Hammond Acceptable; recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies J Heart Lung Transplant 24 2005 34 37
28. M.J. Kim Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response Vaccine 21 2003 1174 1179
29. S. Fagiuoli Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients Transplantation 75 2003 982 986
30. G. Dulai Successful use of lamivudine for severe acute hepatitis B virus infection in a cardiac transplant recipient Transplantation 67 1999 1288 1289
31. D.E. Lammermeier Use of potentially infected donor hearts for cardiac transplantation Ann Thorac Surg 50 1990 222 225
32. W.J. Ko Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area J Heart Lung Transplant 20 2001 865 875
33. R.T. Chung, S. Feng, F.L. Delmonico Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor Am J Transplant 2001 1185 1191